(CRBN) iShares MSCI ACWI Low - Ratings and Ratios
Holding: Stocks, Global Focus: Low-Carbon, Broad-Index
Description: CRBN iShares MSCI ACWI Low
The iShares MSCI ACWI Low Carbon Target ETF (CRBN) is a globally diversified investment vehicle that tracks the MSCI ACWI Low Carbon Target Index, focusing on large-cap stocks across developed and emerging markets while emphasizing low carbon exposure. Its investment strategy is geared towards reducing carbon footprint, making it an attractive option for environmentally conscious investors.
Key Performance Indicators (KPIs) for CRBN include tracking error relative to its benchmark, carbon footprint reduction compared to its parent index, and overall portfolio yield. The ETFs performance is influenced by global economic drivers such as GDP growth rates, interest rates, and currency fluctuations across the countries it invests in. The low carbon target strategy may lead to variations in sector allocation, potentially overweighting sectors with inherently lower carbon intensity, such as technology and healthcare, relative to high-carbon sectors like energy.
The ETFs exposure to global large-cap stocks means its returns are closely tied to the overall performance of international equity markets. Factors such as trade policies, geopolitical events, and macroeconomic trends in major economies (e.g., US, EU, China) will significantly impact CRBNs performance. The funds beta of 1.040 indicates a slightly higher volatility compared to the broader market, suggesting that it may offer slightly higher returns during market upswings but also potentially larger losses during downturns.
Investors in CRBN should monitor the funds tracking efficiency, expense ratio, and the evolving landscape of global environmental regulations and climate change mitigation efforts, as these factors can influence the ETFs investment universe and overall performance. The Assets Under Management (AUM) of $1.04 billion indicates a reasonable scale for the ETF, potentially allowing for tighter bid-ask spreads and lower trading costs.
CRBN ETF Overview
Market Cap in USD | 1,048m |
Category | Global Large-Stock Blend |
TER | 0.20% |
IPO / Inception | 2014-12-08 |
CRBN ETF Ratings
Growth Rating | 81.9% |
Fundamental | - |
Dividend Rating | 62.9% |
Return 12m vs S&P 500 | 1.09% |
Analyst Rating | - |
CRBN Dividends
Dividend Yield 12m | 1.88% |
Yield on Cost 5y | 3.32% |
Annual Growth 5y | 12.29% |
Payout Consistency | 96.9% |
Payout Ratio | % |
CRBN Growth Ratios
Growth Correlation 3m | 94.2% |
Growth Correlation 12m | 70.7% |
Growth Correlation 5y | 71.8% |
CAGR 5y | 20.73% |
CAGR/Max DD 3y | 1.25 |
CAGR/Mean DD 3y | 17.24 |
Sharpe Ratio 12m | 1.54 |
Alpha | 0.00 |
Beta | 0.858 |
Volatility | 8.96% |
Current Volume | 218.9k |
Average Volume 20d | 5.7k |
Stop Loss | 218.2 (-3%) |
Signal | 0.91 |
What is the price of CRBN shares?
Over the past week, the price has changed by +1.65%, over one month by +2.45%, over three months by +9.17% and over the past year by +20.01%.
Is iShares MSCI ACWI Low a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRBN is around 233.97 USD . This means that CRBN is currently overvalued and has a potential downside of 4%.
Is CRBN a buy, sell or hold?
What are the forecasts/targets for the CRBN price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 262.5 | 16.7% |
Last update: 2025-09-05 04:38
CRBN Fundamental Data Overview
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 1.04
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.05b USD (1.05b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 1.05b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.05b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(1.05b)/V(0.0) * Re(9.18%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.18% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for CRBN ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle